FDA NDC Directory · JSON-LD · Markdown
NDC 75834-145 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Nivagen Pharmaceuticals, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA213328 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | TEMOZOLOMIDE (180 mg/1) |
| Marketing started | 20211207 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).